Nearly 40 years ago, Duffy et al. discovered that eBC patients with high uPA proteolytic enzyme activity in their tumours had a significantly shorter disease-free interval, suggesting uPA as a prognostic marker [4]. Here, PLAU is linked to neoplasm.